BEST UNLIMITED TURBO LONG CERTIFICATE - MERCK & CO. | Market Closed - Euronext Paris 12:30:00 2024-05-15 EDT | ||
| 5.23 EUR | +7.84% |
|
| Current month | -3.15% | ||
| 1 month | +8.28% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-15 | 5.23 | +7.84% |
| 24-05-14 | 4.85 | -0.51% |
| 24-05-13 | 4.875 | -8.19% |
| 24-05-10 | 5.31 | +1.92% |
| 24-05-09 | 5.21 | +0.39% |
Real-time Euronext Paris
Last update May 15, 2024 at 12:30 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Société Générale
|
| G961S | |
| ISIN | DE000SU7LXE9 |
| Date issued | 2024-01-29 |
| Strike | 102.5 $ |
| Maturity | Unlimited |
| Parity | 5 : 1 |
| Emission price | 3.88 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.01 € |
|---|---|
| Lowest since issue | 3.51 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.7
USD
Average target price
141.6
USD
Spread / Average Target
+7.52%
- Stock Market
- Certificates
- G961S Certificat